Skip to main content

Articles

Page 4 of 8

  1. Economic evidence is influential in health technology assessment world-wide. Clinical Practice Guidelines (CPG) can enable economists to include economic information on health care provision. Application of ec...

    Authors: Kathryn M. Antioch, Michael F. Drummond, Louis W. Niessen and Hindrik Vondeling

    Citation: Cost Effectiveness and Resource Allocation 2017 15:1

    Content type: Review

    Published on:

  2. In Nepal, pre-eclampsia/eclampsia (PE/E) causes an estimated 21% of maternal deaths annually and contributes to adverse neonatal birth outcomes. Calcium supplementation has been shown to reduce the risk of PE/...

    Authors: Isabelle Feldhaus, Amnesty E. LeFevre, Chandra Rai, Jona Bhattarai, Deirdre Russo, Barbara Rawlins, Pushpa Chaudhary and Kusum Thapa

    Citation: Cost Effectiveness and Resource Allocation 2016 14:13

    Content type: Research

    Published on:

  3. Long-term care for older people is provided in both residential and non-residential settings, with residential settings tending to cater for individuals with higher care needs. Evidence relating to the costs a...

    Authors: Tiffany Easton, Rachel Milte, Maria Crotty and Julie Ratcliffe

    Citation: Cost Effectiveness and Resource Allocation 2016 14:12

    Content type: Review

    Published on:

  4. Zoledronic acid and denosumab were funded by the Australian government for the management of osteoporosis at an equivalent price to alendronate. The price of alendronate has declined by around 65 %, but the pr...

    Authors: Jonathan Karnon, Ainul Shakirah Shafie, Nneka Orji and Sofoora Kawsar Usman

    Citation: Cost Effectiveness and Resource Allocation 2016 14:11

    Content type: Research

    Published on:

  5. The coverage of prevention and treatment strategies for ischemic heart disease and stroke is very low in Ethiopia. In view of Ethiopia’s meager healthcare budget, it is important to identify the most cost-effe...

    Authors: Mieraf Taddesse Tolla, Ole Frithjof Norheim, Solomon Tessema Memirie, Senbeta Guteta Abdisa, Awel Ababulgu, Degu Jerene, Melanie Bertram, Kirsten Strand, Stéphane Verguet and Kjell Arne Johansson

    Citation: Cost Effectiveness and Resource Allocation 2016 14:10

    Content type: Research

    Published on:

  6. Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing due to high cost of HPV vaccine and inexistence of structures to support adolescent vaccination. Alternative sources are ne...

    Authors: Ifeoma Blessing Umeh, Sunday Odunke Nduka and Obinna Ikechukwu Ekwunife

    Citation: Cost Effectiveness and Resource Allocation 2016 14:8

    Content type: Research

    Published on:

  7. To conduct a cost-utility analysis of ranibizumab versus aflibercept for the treatment of patients with visual impairment due to diabetic macular edema (DME) in the Greek setting.

    Authors: Georgia Kourlaba, John Relakis, Ronan Mahon, Maria Kalogeropoulou, Georgia Pantelopoulou, Olga Kousidou and Nikos Maniadakis

    Citation: Cost Effectiveness and Resource Allocation 2016 14:7

    Content type: Research

    Published on:

  8. The objective of this analysis was to determine the value (incremental cost/increment benefit) of a brain LITT system versus employing current surgical options recommended by NCCN guidelines, specifically open...

    Authors: Jeffrey D. Voigt and Gene Barnett

    Citation: Cost Effectiveness and Resource Allocation 2016 14:6

    Content type: Research

    Published on:

  9. The editors of Cost Effectiveness and Resource Allocation would like to thank all our reviewers who have contributed to the journal in volume 13 (2015).

    Authors: Joan Rovira

    Citation: Cost Effectiveness and Resource Allocation 2016 14:5

    Content type: Reviewer acknowledgement

    Published on:

  10. Streptococcus pneumoniae is a common cause of child death. However, the economic burden of pneumococcal disease in low-income countries is poorly described. We aimed to estimate from a...

    Authors: Effua Usuf, Grant Mackenzie, Sana Sambou, Deborah Atherly and Chutima Suraratdecha

    Citation: Cost Effectiveness and Resource Allocation 2016 14:4

    Content type: Research

    Published on:

  11. Newborn mortality, comprising a third of all under-5 deaths, has hardly changed in low and middle income countries (LMICs) including South Africa over the past decade. To attain the MDG 4 target, greater empha...

    Authors: Mandy Maredza, Lumbwe Chola and Karen Hofman

    Citation: Cost Effectiveness and Resource Allocation 2016 14:2

    Content type: Review

    Published on:

  12. Despite improvements in a number of health outcome indicators partly due to the National Health Insurance Scheme (NHIS), Ghana is unlikely to attain all its health-related millennium development goals before t...

    Authors: Robert Kaba Alhassan, Edward Nketiah-Amponsah, James Akazili, Nicole Spieker, Daniel Kojo Arhinful and Tobias F Rinke de Wit

    Citation: Cost Effectiveness and Resource Allocation 2015 13:23

    Content type: Research

    Published on:

  13. The cost-effectiveness of umeclidinium bromide-vilanterol (UMEC/VI) versus tiotropium monotherapy in the UK was assessed using a UMEC/VI treatment-specific economic model based on a chronic obstructive pulmona...

    Authors: Yogesh Suresh Punekar, Graeme Roberts, Afisi Ismaila and Martin O’Leary

    Citation: Cost Effectiveness and Resource Allocation 2015 13:22

    Content type: Research

    Published on:

  14. All international guidelines suggested that Tenofovir and Entecavir are the primary drugs at the first line therapy for the treatment of chronic hepatitis B (CHB). However, in Turkey these medications reimburs...

    Authors: Guvenc Kockaya, Akin Kose, Fatma Betul Yenilmez, Oktay Ozdemir and Ece Kucuksayrac

    Citation: Cost Effectiveness and Resource Allocation 2015 13:21

    Content type: Research

    Published on:

  15. The rapid and continuous growth of health care cost aggravates the frequently low priority and less attention given in financing laboratory services. The poorest countries have the highest out-of-pocket spend...

    Authors: Kasaw Adane, Zenegnaw Abiy and Kassu Desta

    Citation: Cost Effectiveness and Resource Allocation 2015 13:20

    Content type: Research

    Published on:

  16. In the Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST elevation myocardial infarction (FAMOUS) clinical trial, FFR was shown to significantly reduce coro...

    Authors: Julian Nam, Andrew Briggs, Jamie Layland, Keith G. Oldroyd, Nick Curzen, Arvind Sood, Kanarath Balachandran, Raj Das, Shahid Junejo, Hany Eteiba, Mark C. Petrie, Mitchell Lindsay, Stuart Watkins, Simon Corbett, Brian O’Rourke, Anna O’Donnell…

    Citation: Cost Effectiveness and Resource Allocation 2015 13:19

    Content type: Research

    Published on:

  17. Sequential treatment of ankylosing spondylitis (AS) that includes tumour necrosis factor-α antagonists (anti-TNF agents) has been applied in most of the Western countries. Existing cost-effectiveness (CE) mode...

    Authors: An Tran-Duy, Annelies Boonen, Mart A. F. J. van de Laar and Johan L. Severens

    Citation: Cost Effectiveness and Resource Allocation 2015 13:18

    Content type: Research

    Published on:

  18. In the US, the prevalence of hepatitis C virus (HCV) has surpassed the prevalence of human immunodeficiency virus (HIV), with about 3.3 million people chronically infected with the disease. Given the aging of ...

    Authors: Jennifer M. Poonsapaya, Michael Einodshofer, Heather S. Kirkham, Pheophilus Glover and Janeen DuChane

    Citation: Cost Effectiveness and Resource Allocation 2015 13:17

    Content type: Research

    Published on:

  19. Prepaid contributory systems are increasingly being recognized as key mechanisms in achieving universal health coverage in low and middle-income countries. Peru created the Seguro Integral de Salud (SIS) to in...

    Authors: Daniel Cobos Muñoz, Kristian Schultz Hansen, Fern Terris-Prestholt, Fiona Cianci, José Enrique Pérez-Lu, Aldo Lama and Patricia J. García

    Citation: Cost Effectiveness and Resource Allocation 2015 13:16

    Content type: Research

    Published on:

  20. After implementation of the PREDICA annual chest X-ray (CXR) screening program in smokers in the general practice setting of Varese-Italy a significant reduction in lung cancer-specific mortality (18 %) was ob...

    Authors: Paolo Pertile, Albino Poli, Lorenzo Dominioni, Nicola Rotolo, Elisa Nardecchia, Massimo Castiglioni, Massimo Paolucci, William Mantovani and Andrea Imperatori

    Citation: Cost Effectiveness and Resource Allocation 2015 13:15

    Content type: Research

    Published on:

  21. This study was carried out at district level to describe the cost structure and measure the effectiveness of delivering supplementary immunization activity (SIA) and routine immunization (RI) for measles in Be...

    Authors: Landry Kaucley and Pierre Levy

    Citation: Cost Effectiveness and Resource Allocation 2015 13:14

    Content type: Research

    Published on:

  22. Tiotropium (TIO) is a well-established bronchodilator, LAMA (long-acting anticholinergic), for the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD). Clinical evidence suggests ...

    Authors: Oskar Eklund, Faraz Afzal and Fredrik Borgström

    Citation: Cost Effectiveness and Resource Allocation 2015 13:13

    Content type: Research

    Published on:

  23. For end-users of diabetes models that include UKPDS 82 risk equations, an important question is how well these new equations perform. Consequently, the principal objective of this study was to validate the UKP...

    Authors: Philip McEwan, Thomas Ward, Hayley Bennett and Klas Bergenheim

    Citation: Cost Effectiveness and Resource Allocation 2015 13:12

    Content type: Research

    Published on:

  24. Certolizumab pegol, a PEGylated tumour necrosis factor (TNF)-inhibitor, improves the clinical signs and symptoms of rheumatoid arthritis (RA) when used in combination with methotrexate or as monotherapy. This ...

    Authors: Álvaro Hidalgo-Vega, Renata Villoro, Juan Antonio Blasco, Pablo Talavera, Belén Ferro and Oana Purcaru

    Citation: Cost Effectiveness and Resource Allocation 2015 13:11

    Content type: Research

    Published on:

  25. The aim of this study was to compare the cost-utility of the first available single-pill triple combination antihypertensive therapy containing valsartan (V), amlodipine (A) and hydrochlorothiazide (H), with e...

    Authors: Panagiotis Stafylas, Georgia Kourlaba, Magda Hatzikou, Dimitrios Georgiopoulos, Pantelis Sarafidis and Nikolaos Maniadakis

    Citation: Cost Effectiveness and Resource Allocation 2015 13:10

    Content type: Research

    Published on:

  26. Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder which can affect multiple organs of the body, requiring ongoing disease management and healthcare resource utilization. The economic impact o...

    Authors: Cindy Garris, Manan Shah and Eileen Farrelly

    Citation: Cost Effectiveness and Resource Allocation 2015 13:9

    Content type: Research

    Published on:

  27. Globally, diarrhoea is the second leading cause of morbidity and mortality, responsible for the annual loss of about 10% of the total global childhood disease burden. In Tanzania, Rotavirus infection is the ma...

    Authors: George M Ruhago, Frida N Ngalesoni, Bjarne Robberstad and Ole F Norheim

    Citation: Cost Effectiveness and Resource Allocation 2015 13:7

    Content type: Research

    Published on:

  28. Pneumococcal diseases in children under five years are common and preventable. In Colombia there are two pneumococcal conjugate vaccines (PCV) that have proved clinical efficacy. The aim was to estimate the co...

    Authors: Jaime E Ordóñez and John Jairo Orozco

    Citation: Cost Effectiveness and Resource Allocation 2015 13:6

    Content type: Research

    Published on:

  29. In 2004, the largest HIV prevention project (Avahan) conducted globally was implemented in India. Avahan was implemented by NGOs supported by state lead partners in order to provide HIV prevention services to ...

    Authors: Aurélia Lépine, Anna Vassall and Sudhashree Chandrashekar

    Citation: Cost Effectiveness and Resource Allocation 2015 13:5

    Content type: Research

    Published on:

  30. The purpose of this study was to assess the consequences of a national immunization program with HPV vaccine for both boys and girls in Denmark, including the prophylactic effects on all potentially vaccine pr...

    Authors: Jens Olsen and Tine Rikke Jørgensen

    Citation: Cost Effectiveness and Resource Allocation 2015 13:4

    Content type: Research

    Published on:

  31. This paper examines the cost-effectiveness of achieving increases in the use of oral rehydration solution and zinc supplementation in the management of acute diarrhea in children under 5 years through social f...

    Authors: David Bishai, Karampreet Sachathep, Amnesty LeFevre, Hnin New Nwe Thant, Min Zaw, Tin Aung, Willi McFarland and Dominic Montagu

    Citation: Cost Effectiveness and Resource Allocation 2015 13:3

    Content type: Research

    Published on:

  32. Efficient and evidence-based medical device and equipment prioritization is of particular importance in low-income countries due to constraints in financing capacity, physical infrastructure and human resource...

    Authors: Richard J Lilford, Samantha L Burn, Karin D Diaconu, Peter Lilford, Peter J Chilton, Victoria Bion, Carole Cummins and Semira Manaseki-Holland

    Citation: Cost Effectiveness and Resource Allocation 2015 13:2

    Content type: Research

    Published on:

  33. Understanding the cost-effectiveness and affordability of interventions to reduce maternal and newborn deaths is critical to persuading policymakers and donors to implement at scale. The effectiveness of commu...

    Authors: Tim Colbourn, Anni-Maria Pulkki-Brännström, Bejoy Nambiar, Sungwook Kim, Austin Bondo, Lumbani Banda, Charles Makwenda, Neha Batura, Hassan Haghparast-Bidgoli, Rachael Hunter, Anthony Costello, Gianluca Baio and Jolene Skordis-Worrall

    Citation: Cost Effectiveness and Resource Allocation 2015 13:1

    Content type: Research

    Published on:

  34. Harm reduction strategies commonly include needle and syringe programmes (NSP), opioid substitution therapy (OST) and interventions combining these two strategies. Despite the proven effectiveness of harm-redu...

    Authors: Sung Wook Kim, Anni-Maria Pulkki-Brannstrom and Jolene Skordis-Worrall

    Citation: Cost Effectiveness and Resource Allocation 2014 12:25

    Content type: Research

    Published on:

  35. The question of how to value lost productivity in economic evaluations has been subject of debate in the past twenty years. According to the Washington panel, lost productivity influences health-related qualit...

    Authors: Saskia Knies, Annelies Boonen and Johan L Severens

    Citation: Cost Effectiveness and Resource Allocation 2014 12:24

    Content type: Research

    Published on:

  36. Research priority setting aims to gain consensus about areas where research effort will have wide benefits to society. While general principles for setting health research priorities have been suggested, there...

    Authors: Jamie Bryant, Rob Sanson-Fisher, Justin Walsh and Jessica Stewart

    Citation: Cost Effectiveness and Resource Allocation 2014 12:23

    Content type: Review

    Published on:

  37. There is an increased interest in the use of multi-criteria decision analysis (MCDA) to support regulatory and reimbursement decision making. The EVIDEM framework was developed to provide pragmatic multi-crite...

    Authors: Janine van Til, Catharina Groothuis-Oudshoorn, Marijke Lieferink, James Dolan and Mireille Goetghebeur

    Citation: Cost Effectiveness and Resource Allocation 2014 12:22

    Content type: Research

    Published on:

  38. In Benin, malaria was the leading cause of hospital consultation for children less than 5 years old (47.2%), and for all patients not hospitalized (42.3%). Its incidence among those who attended a health facil...

    Authors: Charles Patrick Makoutodé, Martine Audibert and Achille Massougbodji

    Citation: Cost Effectiveness and Resource Allocation 2014 12:21

    Content type: Research

    Published on:

  39. Tuberculosis remains the leading cause of death in South Africa. A number of potential new TB vaccine candidates have been identified and are currently in clinical trials. One such candidate is MVA85A. This st...

    Authors: Liezl Channing and Edina Sinanovic

    Citation: Cost Effectiveness and Resource Allocation 2014 12:20

    Content type: Research

    Published on:

  40. Iron-deficiency anemia (IDA) is prevalent in patients with advanced chronic heart failure (CHF). It affects the patients’ overall physical condition and is suggested as a strong outcome predictor in CHF. Recen...

    Authors: Eun-A Lim, Hyun-Soon Sohn, Haeyoung Lee and Sang-Eun Choi

    Citation: Cost Effectiveness and Resource Allocation 2014 12:19

    Content type: Research

    Published on:

  41. This Guidance for Priority Setting in Health Care (GPS-Health), initiated by the World Health Organization, offers a comprehensive map of equity criteria that are relevant to health care priority setting and s...

    Authors: Ole F Norheim, Rob Baltussen, Mira Johri, Dan Chisholm, Erik Nord, DanW Brock, Per Carlsson, Richard Cookson, Norman Daniels, Marion Danis, Marc Fleurbaey, Kjell A Johansson, Lydia Kapiriri, Peter Littlejohns, Thomas Mbeeli, Krishna D Rao…

    Citation: Cost Effectiveness and Resource Allocation 2014 12:18

    Content type: Methodology

    Published on:

  42. The aim of the study was to investigate the changes in costs and outcomes after the implementation of various disease management programs (DMPs), to identify their potential determinants, and to compare the co...

    Authors: Apostolos Tsiachristas, Jane Murray Cramm, Anna P Nieboer and Maureen PMH Rutten-van Mölken

    Citation: Cost Effectiveness and Resource Allocation 2014 12:17

    Content type: Research

    Published on:

  43. To aid informed health sector decision-making, data from sufficient high quality economic evaluations must be available to policy makers. To date, no known study has analysed the quantity and quality of availa...

    Authors: Hassan Haghparast-Bidgoli, Aliasghar Ahmad Kiadaliri and Jolene Skordis-Worrall

    Citation: Cost Effectiveness and Resource Allocation 2014 12:15

    Content type: Review

    Published on:

  44. High maternal and infant mortality continue to be major challenges to the attainment of the Millennium Development Goals for many low and middle-income countries. There is now evidence that voucher initiatives...

    Authors: Chrispus Mayora, Elizabeth Ekirapa-Kiracho, David Bishai, David H Peters, Olico Okui and Sebastian Olikira Baine

    Citation: Cost Effectiveness and Resource Allocation 2014 12:14

    Content type: Research

    Published on:

Annual Journal Metrics